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Human v 9v 2+ T-Cell Repertoireγ δ
Carrie R. Willcox*, Martin S. Davey and Benjamin E. Willcox*
Cancer Immunology and Immunotherapy Centre, Institute for Immunology and Immunotherapy, University of Birmingham, 
Birmingham, United Kingdom
Vγ9Vδ2+ lymphocytes are among the first T-cells to develop in the human fetus and are 
the predominant peripheral blood γδ T-cell population in most adults. Capable of broad 
polyclonal responses to pyrophosphate antigens (pAg), they are implicated in immunity 
to a diverse range of infections. Previously Vγ9Vδ2+ development was thought to involve 
postnatal selection and amplification of public Vγ9 clonotypes in response to microbial 
stimuli. However, recent data indicate the Vγ9Vδ2+ T-cell receptor (TCR) repertoire, 
which is generated early in gestation, is dominated by public Vγ9 clonotypes from birth. 
These chains bear highly distinct features compared to Vγ9 chains from Vδ1+ T-cells, due 
either to temporal differences in recombination of each subset and/or potentially prenatal 
selection of pAg-reactive clonotypes. While these processes result in a semi-invariant 
repertoire featuring Vγ9 sequences preconfigured for pAg recognition, alterations in 
TCRδ repertoires between neonate and adult suggest either peripheral selection of clo-
notypes responsive to microbial antigens or altered postnatal thymic output of Vγ9Vδ2+ 
T-cells. Interestingly, some individuals demonstrate private Vγ9Vδ2+ expansions with 
distinct effector phenotypes, suggestive of selective expansion in response to microbial 
stimulation. The Vγ9Vδ2+ T-cell subset, therefore, exhibits many features common to 
mouse γδ T-cell subsets, including early development, a semi-invariant TCR repertoire, 
and a reliance on butyrophilin-like molecules in antigen recognition. However, impor-
tantly Vγ9Vδ2+ T-cells retain TCR sensitivity after acquiring an effector phenotype. We 
outline a model for Vγ9Vδ2+ T-cell development and selection involving innate prenatal 
repertoire focusing, followed by postnatal repertoire shifts driven by microbial infection 
and/or altered thymic output.
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DeveLOPMenT OF THe vγ9vδ2+ T-CeLL COMPARTMenT
Vγ9Vδ2+ lymphocytes are the predominant γδ T-cell subset in healthy adult peripheral blood. 
Essentially all Vγ9Vδ2+ T-cells respond to small pyrophosphate antigens (pAg) (1) in a T-cell recep-
tor (TCR)-dependent manner (2), a process dependent on target cell expression of the butyrophilin 
(BTN) family member BTN3A1 (3). The population expands during childhood (4), typically com-
prising ~1–10% of total peripheral blood T-cells in healthy adults.
The Vγ9 and Vδ2 variable (V) gene segments are the first γ/δ chains to undergo rearrangement in 
development, detected in fetal liver from as early as 5–6 weeks gestation (5), and in fetal thymus after 
8 weeks gestation (6). By mid-gestation (20–30 weeks), Vγ9Vδ2+ T-cells dominate the γδ repertoire 
(7) (Figure 1). However, Vδ1+ T-cell generation increases later in gestation, and Vδ1+ T-cells comprise 
FiguRe 1 | Schematic depiction of Vγ9Vδ2+ T cell generation and selection throughout life. Vγ9Vδ2+ T cells as a percentage of total peripheral blood γδ T cells 
throughout life (black line, left axis). Jδ usage among Vγ9Vδ2+ T cells (red lines, right axis) throughout life.
2
Willcox et al. Development/Selection of Vγ9Vδ2+ T-Cell
Frontiers in Immunology | www.frontiersin.org July 2018 | Volume 9 | Article 1501
the majority of the γδ repertoire in cord blood (7, 8), and in pediatric 
thymus (9). It is unclear whether gestationally produced Vγ9Vδ2+ 
cells persist in fetal blood, and become outnumbered by subse-
quent Vδ1+ T-cell production, or whether most Vγ9Vδ2+ T-cells 
exit circulation and populate the tissues. However, the dramatic 
postnatal numerical expansion of Vγ9Vδ2+ T-cells likely occurs 
following microbial exposure, with the Vγ9Vδ2+ subset ultimately 
dominating the circulating γδ T-cell repertoire during childhood 
(4, 10). Consistent with this, Vγ9Vδ2+ T-cells mature in phenotype 
early after birth concomitant with their numerical expansion (4); 
moreover, several infections stimulate Vγ9Vδ2+ expansion, and 
tellingly, identical twins have different Vγ9Vδ2+ profiles (4).
THe vγ9vδ2+ TCR RePeRTOiRe  
in HeALTHY ADuLTS
Early studies identified Vγ9Vδ2+ TCR features required for pAg 
responsiveness. Interestingly, adult Vδ2 CDR3s were highly diverse, 
composed of Vδ2 joined to one (or occasionally two) diversity (D) 
segments (usually Dδ3), and typically used joining (J) segment 
Jδ1 (11, 12). A hydrophobic amino acid, typically Val/Leu/Ile at 
position 97 of the Vδ2 framework (position 5 of the CDR3, defined 
as the amino acids between the Vδ2 segment C-terminal Cys and 
the conserved Phe of the J segment), generated by N-nucleotide 
addition, was required for pAg recognition (12, 13).
Conversely, Vγ9 gene segments were relatively restricted in CDR3γ 
sequence and length, and exclusively utilized JγP and constant 
region Cγ1 (11, 14, 15). One clonotype (CALWEVQELGKKIKVF), 
generated by germline Vγ9-JγP recombination with minimal 
nucleotide trimming and no N-nucleotide addition, was present 
in many healthy donors (15). Further low-throughput analyses 
detected many “public” Vγ9 clonotypes in multiple individuals 
(16). Although peripheral blood γδ T-cell numbers vary widely 
between individuals and are influenced by age and sex (17), public 
clonotypes are conserved irrespective of age, sex, and race (16), 
and between cord blood and adult (18). Although the presence of 
such public Vγ9 sequences was thought to reflect strong postnatal 
peripheral selection and amplification of specific clonotypes fol-
lowing microbial exposure (19), an improved understanding of 
the Vγ9Vδ2+ TCR repertoire suggests alternative possibilities.
eviDenCe FOR COnveRgenT 
ReCOMBinATiOn in THe vγ9 TCR 
RePeRTOiRe
Deep sequencing analyses of Vγ9Vδ2+ TCR repertoires (20–23) 
have confirmed a high frequency of public Vγ9 clonotypes in 
adult Vγ9Vδ2+ T-cells, and reveal the basis for Vγ9 TCR public-
ity. The most prevalent of these, CALWEVQELGKKIKVF, high-
lighted in many previous studies (7, 11, 15, 16, 18), comprised 
TABLe 1 | Common public Vγ9-JγP sequences can be generated by convergent recombination.
vγ9 P n P JγP P 
nt
n 
nt
germline TgT gCC TTg Tgg gAg gTg T ggg CAA gAg TTg ggC AAA AAA ATC AAg gTA TTT
CALWevQELGKKIKVF
TGT GCC TTG TGG GAG GTG CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 0
TGT GCC TTG TGG GAG GT C CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 1
TGT GCC TTG TGG GAG GT A CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 1
TGT GCC TTG TGG GAG GT T CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 1
TGT GCC TTG TGG GAG GTG CA G GAG TTG GGC AAA AAA ATC AAG GTA TTT 2 1
CALWevRELGKKIKVF
TGT GCC TTG TGG GAG GTG C G A GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 1
TGT GCC TTG TGG GAG GTG AG A GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 2
TGT GCC TTG TGG GAG GTG C GT GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 2
TGT GCC TTG TGG GAG GTG C GC GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 2
TGT GCC TTG TGG GAG GTG C GG GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 2
CALWeAQELGKKIKVF
TGT GCC TTG TGG GAG G CA CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 2
TGT GCC TTG TGG GAG G CC CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 2
TGT GCC TTG TGG GAG G CG CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 2
TGT GCC TTG TGG GAG G CT CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 2
CALWevLELGKKIKVF
TGT GCC TTG TGG GAG GTG C T A GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 1
TGT GCC TTG TGG GAG GTG C TG GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 2
TGT GCC TTG TGG GAG GTG C TT GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 2
TGT GCC TTG TGG GAG GTG C TC GAG TTG GGC AAA AAA ATC AAG GTA TTT 1 2
CALWeQELGKKIKVF
TGT GCC TTG TGG GAG CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 0
TGT GCC TTG TGG GA A CAA GAG TTG GGC AAA AAA ATC AAG GTA TTT 0 1
Vγ9 and JγP gene segments are subject to nuclease activity, non-templated (N) nucleotide addition, and incorporation of palindromic (P) nucleotides, during recombination. Above 
are shown some of the possible different nucleotide sequences observed that generate the same CDR3 amino acid sequences, for five of the most common public Vγ9 sequences. 
N-nucleotides are shown in red and P-nucleotides are shown in blue.
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between 4 and 45% of the Vγ9 repertoire (20–22). As noted (15), 
this amino acid sequence can be generated by near-germline 
recombination of Vγ9 and JγP gene segments with minimal 
nucleotide trimming and no N-nucleotide addition. However, 
it can also result from several different nucleotide sequences: 
(1) involving trimming of nucleotides at the 3′ end of the V 
region and/or 5′ end of the J region, (2) incorporation of one 
or more palindromic (P)-nucleotides, and/or (3) addition of 
one or several non-templated (N)-nucleotides by terminal 
deoxynucleotide transferase (TdT), resulting in the same amino 
acid sequence (Table 1). Moreover, other public Vγ9 clonotypes 
can be generated in multiple ways depending on the extent of 
V and J gene segment trimming, and N/P-nucleotide addition 
(Table 1) (23).
These features suggest the publicity of the Vγ9 repertoire is due to 
convergent recombination, a phenomenon proposed for generation 
of public TCRβ repertoires (24), whereby distinct recombination 
events “converge” to generate the same nucleotide sequences, 
and multiple nucleotide sequences “converge” to encode the 
same amino acid sequence. Venturi et  al. proposed that public 
TCRβ responses arise from clonotypes with a high precursor fre-
quency in two ways. Public sequences could arise independently 
multiple times in each individual by convergent recombina-
tion. Alternatively, precursor frequency could be increased if a 
single TCRβ rearrangement, which undergoes several rounds 
of proliferation after pre-TCR selection, could pair with many 
TCRα chains. Importantly, γδ T-cells do not undergo pre-TCR 
selection or proliferate after successful TCRγ rearrangement (but 
before TCRδ rearrangement) during T-cell development. Public 
Vγ9 sequences observed in adults must, therefore, result from 
convergent recombination.
High throughput Vδ2 TCR repertoire sequencing analyses pro-
vide corroborating evidence for convergent Vγ9 recombination. 
CDR3δ2 repertoires are more diverse than CDR3γ9 repertoires 
derived from Vγ9Vδ2+ T-cells from most adults (21, 23). Therefore, 
prevalent Vγ9 clonotypes (e.g., CALWEVQELGKKIKVF) do not 
reflect clonal expansion (if so equally large Vδ2 clonotypes would 
also be observed), but are likely recombined independently 
multiple times and pair with distinct Vδ2 chains. Single cell PCR 
in several individuals has substantiated the feasibility of this hypoth-
esis, establishing unequivocally that public Vγ9 CDR3 clonotypes 
each paired with multiple Vδ2 clonotypes (23), confirming that 
public Vγ9 sequences arise frequently and independently. These 
findings prove that “convergent recombination” is an inherent 
feature of the Vγ9 repertoire, in keeping with public sequences 
exhibiting high precursor frequency because they have arisen via 
many independent recombination events in each donor. They 
also raise the question of whether, rather than requiring selective 
postnatal clonotypic expansion, the prevalence of public Vγ9 
sequences may be preconfigured since birth.
4Willcox et al. Development/Selection of Vγ9Vδ2+ T-Cell
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SHAPing OF THe ADuLT vγ9vδ2 TCR 
RePeRTOiRe: POSTnATAL SeLeCTiOn
An intriguing question is whether Vγ9Vδ2+ T-cells expand en 
masse following microbial exposure during early childhood, 
concurrent with phenotypic maturation (4, 10), or whether 
dominant clonotypic selection operates, resulting in prevalent 
public Vγ9 clonotypes in adults (19). Of relevance, a recent study 
has compared adult peripheral blood with cord blood Vγ9Vδ2+ 
TCR repertoires (23). Importantly, the most prevalent public 
Vγ9 clonotype (CALWEVQELGKKIKVF) in the fetus (7) was 
also prevalent in cord (18, 23) and remains dominant in most 
adults (18, 20, 21). Moreover, other public Vγ9 clonotypes are 
frequently found in all these populations (16, 23). Also, the 
CDR3δ lengths in cord blood and adult peripheral blood are 
similar (23). Therefore, the public Vγ9 clonotypes present in adult 
peripheral blood Vγ9Vδ2+ T-cells are present at similar relative 
frequencies in cord blood Vγ9Vδ2+ T-cells. Furthermore, there 
were relatively subtle changes in the diversity of Vδ2-associated 
Vγ9 TCR repertoire from neonate to adult (23).
Despite these observations, postnatal changes in the Vδ2 rep-
ertoire are ultimately inconsistent with the concept of Vγ9Vδ2+ 
T-cell expansion en masse. Crucially, most Vγ9Vδ2+ cells in adult 
peripheral blood express Vδ2 recombined with Jδ1 (12), whereas 
in the cord blood most Vδ2 rearrangements use Jδ3, and to a lesser 
degree Jδ2 (12, 23) (Figure 1). This difference could be explained 
in two ways. One possibility is that extrathymic selection of spe-
cific clonotypes may occur in response to microbial exposure. Of 
relevance, it is currently unclear whether cord blood Vγ9Vδ2-Jδ3 
cells are reactive to common pAg. While most Vδ2-Jδ1+ sequences 
in cord blood do generally contain a hydrophobic amino acid at 
position 5 (a motif previously linked to pAg reactivity) (23), fewer 
Vδ2-Jδ3+ sequences contain this motif (23). Consistent with this, 
Vγ9Vδ2+ T-cells from cord blood are generally less responsive to 
pAg than adult Vγ9Vδ2+ T-cells (10, 18, 25), however, the Vδ2 
repertoire of responsive cells has not been reported, and conceiv-
ably only Vδ2-Jδ1 TCRs were responding in these assays.
A second possibility that could explain postnatal alterations 
in the Vδ2 TCR repertoire is a second wave of Vγ9Vδ2+ T-cell 
production after birth. Thymic Vγ9Vδ2+ T-cell output is thought 
to decrease after birth, based on failure to detect Vγ9 or Vδ2 
gene expression in pediatric thymus samples (26), or detection 
of <10% of thymocytes expressing Vδ2 in thymi from children 
(4, 9). Surprisingly, Vγ9 expression was not detected in the thymus 
during childhood, despite its co-expression by Vδ1+ cells (21), 
which continue to be generated after birth (4, 26). Conceivably 
this issue warrants reinvestigation, and perhaps postnatal thymic 
Vγ9Vδ2+ T-cell generation has been underappreciated. Consistent 
with this, Ravens (22) and others (27, 28) have shown Vγ9Vδ2+ 
T-cell reconstitution following stem cell transplantation. Newly 
generated Vγ9Vδ2+ T-cells presumably originate in the recipient’s 
thymus (22). Detailed comparison of Vδ2-Jδ1 sequences in cord 
blood and adult repertoires (23) also hints at postnatal Vγ9Vδ2+ 
T-cell production. Although Vδ2-Jδ1 clonotypes are relatively 
uncommon in cord blood (most use Vδ2-Jδ3 at that time), 
those present often have shorter CDR3s, incorporating fewer 
N-nucleotides [as observed in fetal liver (5)] in comparison to 
the longer, more private Vδ2-Jδ1 clonotypes observed in adults. 
However, if the Vγ9Vδ2+ T-cells that predominate in adults are 
indeed generated in the postnatal thymus, we have observed no 
obvious differences in the Vγ9 repertoire of these cells, suggesting 
that the thymus continues to generate Vγ9-JγP rearrangements 
with low diversity even when TdT is expressed and when Vγ9 
CDR3s found in Vδ1+ cells are highly diverse (21).
eviDenCe FOR PRenATAL SHAPing  
OF THe vγ9vδ2+ TCR RePeRTOiRe
Postnatal processes clearly strongly influence the Vγ9Vδ2+ T-cell 
compartment. However, other events may also shape the prenatal 
Vγ9Vδ2+ repertoire (Figure  1). The Vγ9 repertoire is already 
highly restricted in CDR3 length during gestation, with public 
clonotypes evident (7), consistent with the cord blood Vγ9 reper-
toire (23). This indicates postnatal pAg exposure is not required 
for the selection of these features. However, the possibility that 
there might be some selection for pAg-reactive semi-invariant 
Vγ9Vδ2+ T  cells before postnatal microbial exposure has been 
suggested previously (7), which potentially could operate intra- or 
extra-thymically. Conceivably, this could involve elevated levels 
of endogenous pAgs such as IPP derived from fetal isoprenoid 
metabolism, or pAg derived from placental microbiota; in addi-
tion, a specific selecting element, such as one or more of the BTN3 
gene products could be involved (7). Bearing these possibilities 
in mind, enrichment of Jδ3 within cord blood Vδ2 sequences 
relative to adult peripheral blood could relate to more permissive 
positive selection of clonotypes responding to such fetal-specific 
selection events relative to postnatal responsiveness to exogenous 
microbially derived pAg. However, alternatively, genetic processes 
may explain the restricted nature of the Vγ9 repertoire in fetal and 
cord blood Vδ2+ cells. Consistent with this suggestion, the mouse 
OP9-DL1 thymic organ culture system can support Vγ9Vδ2+ 
T cell generation (9), arguing against a stringent positive selec-
tion step involving BTN3A1/pAg-mediated events. Of relevance 
to inherent genetic bias in Vγ9 chain recombination, whereas 
Vδ1-associated Vγ9 chains are diverse in length and rarely use 
JγP, Vδ2-associated Vγ9 CDR3 sequences are restricted in length, 
and exclusively utilize JγP, including in adults. These differences 
could merely reflect changes in gene segment accessibility during 
Vγ9Vδ2+ T-cell generation in early gestation, or regulation of Vγ9 
chain recombination that favor simpler public Vγ9 rearrangements 
during the earlier timescale of fetal Vγ9Vδ2+ T-cell generation, 
before TdT is expressed (i.e., before 20 weeks of gestation) (29).
COMPARiSOnS BeTween vγ9vδ2+ 
T-CeLLS AnD SeMi-invARiAnT MOuSe 
γδ T-CeLL SuBSeTS
Several features of the Vγ9Vδ2+ compartment suggest similarities 
to mouse γδ T-cell subsets (30). The early fetal wave of Vγ9Vδ2+ 
production, combined with the semi-invariant Vγ9Vδ2+ TCR 
repertoire, mirrors early waves of semi-invariant mouse γδ T-cells. 
The first T-cells to develop in mouse fetal thymus are Vγ5Vδ1+ 
dendritic epidermal T-cells, which have limited junctional 
5Willcox et al. Development/Selection of Vγ9Vδ2+ T-Cell
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diversity in both TCR chains (31). This is followed by produc-
tion of Vγ6Vδ1 TCRs, also of limited diversity, then postnatal 
production of more diverse γδ T-cell populations using Vγ4, 
Vγ1, and Vγ7 chains (32). Some of these γδ populations undergo 
intrathymic or extrathymic selection events. DETC cells undergo 
intrathymic selection involving the BTN family member Skint1 
(33, 34); the Vγ7 repertoire requires the presence of BTNL1/6 
for extrathymic intestinal selection (35). Another semi-invariant 
mouse population expresses Vγ4 sequences of restricted length 
and diversity (analogous to public human Vγ9 sequences) with a 
germline-encoded Vδ5-Dδ2-Jδ1 sequence (36, 37), although its 
role and the signals that drive selection are unknown. The pres-
ence of γδ T-cells expressing semi-invariant TCRs in both mice 
and humans suggests this may reflect a shared paradigm for gen-
eration of T-cell populations with uniform reactivity to particular 
antigenic epitopes. Consistent with a related immunobiology, 
both BTN3A1 and BTN3A2/3 are important for Vγ9Vδ2+ T-cell 
recognition (38). However, while some semi-invariant mouse γδ 
T-cell populations can become hyporesponsive to TCR trigger-
ing following initial strong TCR signaling during development 
(39), this does not apparently apply to human Vγ9Vδ2+ T-cells. 
Notably Vγ9Vδ2+ T-cells remain responsive to both pAg and anti-
CD3 stimulation, a feature which underlies their potential use in 
several cancer immunotherapy applications (40), and they also 
exhibit the potential for further TCR-mediated plasticity (41–44).
POTenTiAL FOR CLOnAL FOCuSing in 
ReSPOnSe TO inFeCTiOuS/STReSS 
CHALLenge
Although clear evidence supports a broad polyclonal Vγ9Vδ2+ 
T-cell response to pAg, the extent to which clonotype-specific 
responses occur remains unclear. Vγ9Vδ2+ T-cells expand in 
various infections (1) but TCR clonality is uncharacterized in 
most scenarios. While most healthy donors have similar Vγ9 
repertoires composed of up to 80% public Vγ9 clonotypes and 
diverse Vδ2 clonotypes (23), a minority of healthy donors have 
one or several expanded Vγ9 and Vδ2 clonotypes reminiscent of 
Vδ1 expansions (21), with the top clone comprising 20–40% of all 
Vγ9 and Vδ2 CDR3s (23). These clones express Vγ9 clonotypes 
shared less frequently between adult donors, often with longer or 
more complex CDR3s containing more added N-nucleotides. In 
these donors, a Vδ2 clonotype of similar frequency is detected, 
and pairing of the top Vγ9 and Vδ2 clonotypes can be confirmed 
by single cell PCR. This clonal expansion correlated with a change 
in Vδ2+ T-cell phenotype to CD45RAnegCD27neg (23), distinct 
from the CD45RAnegCD45RO+CD27+ phenotype observed in 
most healthy donors (45). The factors driving this clonal expan-
sion and phenotypic maturation in these seemingly healthy 
donors are unclear. Ryan et al. (46) have also observed healthy 
donors with Vγ9Vδ2+ T-cells of differing effector phenotypes, 
although the clonality of Vγ9Vδ2+ T-cells was not examined. 
Expansion of particular Vδ2 clonotypes has also been noted in 
tuberculosis (47, 48), human leprosy (49), and in a macaque 
tuberculosis model (50). Public Vγ9 clonotypes were not shown 
to change during BCG infection in macaques (51), however, a 
lack of Vδ TCR clonotype data could have obscured the presence 
of clonotypic expansions with distinct Vδ2 chains. Conceivably 
clonal expansion may occur after Epstein–Barr virus or other 
common viral infections, and may underlie clonal expansions 
observed in otherwise healthy donors. Moreover, it is unclear 
how expansion of particular Vγ9Vδ2+ clonotypes helps protect 
the host, given the polyclonal response of Vγ9Vδ2+ T-cells to 
pAg. Conceivably expanded clones could respond with higher 
avidity, or alternatively could be reactive to different pathogen-
specific stimuli, such as chemically diverse antigens. Additional 
work will no doubt address these questions.
COnCLuSiOn
In summary, we suggest Vγ9Vδ2+ T-cell development is shaped by 
both prenatal and postnatal events (Figure 1), which impact TCR 
repertoire and pAg reactivity. Importantly, the human Vγ9Vδ2+ 
TCR repertoire is composed of highly public Vγ9 chains produced 
by frequent recombination events that occur in every individual, 
resulting in a semi-invariant repertoire largely preconfigured from 
birth for pAg reactivity. These Vγ9 chains may undergo prenatal 
selection based on pAg reactivity, or unknown factors may con-
strain Vγ9-JγP rearrangements. Alongside public Vγ9 sequences, 
the Vδ2 repertoire is very diverse and private, and changes between 
neonatal and adult Vδ2 TCR repertoires suggest several selection 
events throughout life. Vδ2-Jδ3 TCRs are prevalent in cord blood 
and these may be positively selected in fetal development for recog-
nition of host pAgs, or these rearrangements may be preferentially 
generated in early gestation. Vδ2-Jδ1 chains with longer CDR3 
and hydrophobic amino acids at position 5 ultimately dominate 
the Vδ2 repertoire in adults, and these may be selected from rare 
rearrangements in cord blood following microbial pAg exposure, 
or further Vγ9Vδ2+ T-cell generation may occur in the postnatal 
thymus. Nevertheless, these selection events produce a repertoire 
that exploits the somatically recombined Vγ9Vδ2+ TCR as a sur-
rogate pattern recognition receptor to sense pAgs. Further clonal 
selection appears to occur in some healthy adults and during some 
infections, however, exactly what protection such favored clono-
types provide that are not provided already by the broad Vγ9Vδ2+ 
TCR repertoire is an intriguing question future studies can address.
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